Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Assets (2016 - 2025)

Wave Life Sciences' Other Non-Current Assets history spans 11 years, with the latest figure at $16000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 99.58% year-over-year to $16000.0; the TTM value through Dec 2025 reached $16000.0, down 99.58%, while the annual FY2025 figure was $16000.0, 99.58% down from the prior year.
  • Other Non-Current Assets reached $16000.0 in Q4 2025 per WVE's latest filing, down from $22000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $4.7 million in Q1 2023 to a low of $16000.0 in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $2.1 million, with a median of $1.8 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: surged 2335.9% in 2024, then tumbled 99.58% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $3.7 million in 2021, then changed by 0.0% to $3.7 million in 2022, then plummeted by 95.78% to $156000.0 in 2023, then soared by 2335.9% to $3.8 million in 2024, then crashed by 99.58% to $16000.0 in 2025.
  • Per Business Quant, the three most recent readings for WVE's Other Non-Current Assets are $16000.0 (Q4 2025), $22000.0 (Q3 2025), and $728000.0 (Q2 2025).